CEL-SCI Corp(CVM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVM CEL-SCI Corp

盘前交易 12-08 06:31:11 EST

6.45

+0.16

+2.54%

最高6.69	最低6.26	成交量6.32万
今开6.60	昨收6.29	日振幅6.84%
总市值5,170万	流通市值4,280万	总股本801.60万
成交额40.89万	换手率0.95%	流通股本663.50万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVM","market":"US","secType":"STK","nameCN":"CEL-SCI Corp","latestPrice":6.45,"timestamp":1764968400000,"preClose":6.29,"halted":0,"volume":63154,"delay":0,"floatShares":6635021,"shares":8016035,"eps":-9.081257,"marketStatus":"盘前交易","change":0.16,"latestTime":"12-08 06:31:11 EST","open":6.6,"high":6.69,"low":6.26,"amount":408900.91131,"amplitude":0.068362,"askPrice":7.2,"askSize":9,"bidPrice":5.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-9.081257,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765204200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":433828800000,"exchange":"AMEX","adjPreClose":6.45,"postHourTrading":{"tag":"盘后","latestPrice":6.45,"preClose":6.45,"latestTime":"19:46 EST","volume":36,"amount":232.18,"timestamp":1764982013706},"volumeRatio":0.8380887191212595,"impliedVol":1.3611,"impliedVolPercentile":0.6545},"requestUrl":"/m/hq/s/CVM","defaultTab":"news","newsList":[{"id":"2584132525","title":"Cel-Sci Corporation盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584132525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584132525?lang=zh_cn&edition=full","pubTime":"2025-11-20 03:23","pubTimestamp":1763580227,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日03时23分，Cel-Sci Corporation股票出现异动，股价大幅跳水5.08%。截至发稿，该股报6.35美元/股，成交量4.387万股，换手率0.55%，振幅5.16%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为1.14%。其相关个股中，Nuvation Bio Inc.、Kazia Therapeutics Limited、Annexon, Inc.涨幅较大，Kazia Therapeutics Limited、Clearmind Medicine Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为1493.81%、164.49%、61.59%，振幅较大的相关个股有Tempest Therapeutics, Inc.、Nuvation Bio Inc.、Biovie Inc C/Wts 08/08/2030，振幅分别为51.37%、50.21%、40.00%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120032347950f072f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120032347950f072f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2579494193","title":"Cel-Sci Corporation盘中异动 股价大跌5.87%报8.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579494193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579494193?lang=zh_cn&edition=full","pubTime":"2025-10-28 23:46","pubTimestamp":1761666360,"startTime":"0","endTime":"0","summary":"北京时间2025年10月28日23时46分，Cel-Sci Corporation股票出现波动，股价快速下挫5.87%。截至发稿，该股报8.50美元/股，成交量3.0597万股，换手率0.38%，振幅7.53%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Dermata Therapeutics Inc C/Wts 、Arcutis Biotherapeutics, Inc.涨幅较大，Aditxt, Inc.、Genprex, Inc.、Bio Green Med Solution, Inc.较为活跃，换手率分别为2319.17%、369.08%、271.12%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ethzilla Corporation C/Wts 06/11/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为87.82%、56.34%、41.70%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028234600a47a1c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028234600a47a1c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2567770701","title":"信达生物将在第34届欧洲皮肤病学会（EADV）2025年会公布综合管线免疫领域多项研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2567770701","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567770701?lang=zh_cn&edition=full","pubTime":"2025-09-16 09:00","pubTimestamp":1757984400,"startTime":"0","endTime":"0","summary":"2025年9月16日美国旧金山和中国苏州 /美通社/ -- 信达生物制药集团，一家致力于研发、生产和销售肿瘤、自身免疫、代谢及心血管、眼科等重大疾病领域创新药物的生物制药公司，今日宣布，将在2025年欧洲皮肤病学会年会上公布综合管线的多项最新研究数据，包括匹康奇拜单抗的临床II期及III期研究事后分析，IBI3013和IAR129的临床前研究。截至目前，信达生物患者援助项目已惠及17余万普通患者，药物捐赠总价值34亿元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4773327_ZH73327_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1969619763.USD","LU2097828714.EUR","BK1583","BK4139","LU0502904849.HKD","LU2097828474.EUR","IVBIY","LU2097828631.EUR","LU2097828805.USD","LU2328871848.SGD","LU2488822045.USD","BK1589","01801","LU2242644610.SGD","LU2097828557.USD","BK1161","LU0455707207.USD","CVM"],"gpt_icon":0},{"id":"2562593710","title":"CEL-SCI股价重挫逾30%，此前宣布完成1000万美元公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=2562593710","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562593710?lang=zh_cn&edition=full","pubTime":"2025-08-28 22:51","pubTimestamp":1756392660,"startTime":"0","endTime":"0","summary":"美股周四早盘，生物技术公司CEL-SCI（CVM）股价重挫30.44%，此前该公司宣布完成1000万美元公开发行定价，以每股9.00美元的价格出售1111200股普通股。\n　　该发行预计将于2025年8月29日完成，所筹资金将用于一般企业用途。\n　　CEL-SCI公司主要从事利用免疫系统治疗癌症和其他疾病的研究和开发，致力于激活免疫系统以对抗癌症和传染病。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-28/doc-infnqery6598922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2562085455","title":"信达生物盘中异动 股价大涨3.02%报93.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562085455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562085455?lang=zh_cn&edition=full","pubTime":"2025-08-28 10:11","pubTimestamp":1756347063,"startTime":"0","endTime":"0","summary":"2025年08月28日早盘10时11分，信达生物股票出现异动，股价急速拉升3.02%。信达生物股票所在的药品行业中，整体涨幅为0.08%。该信息摘要如下：信达生物公布中期业绩，2025年上半年，公司实现总收入人民币59.531亿元，同比增长50.6%，这主要得益于肿瘤产品的强劲表现、综合产品线的扩展以及许可费收入的增加。截至2025年6月30日止六个月，期内利润达人民币8.343亿元，较截至2024年6月30日止六个月的亏损人民币3.926亿元增加人民币12.269亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828101105a4a3d06e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828101105a4a3d06e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADC","CVM","BK4080","BK4139","BK4231"],"gpt_icon":0},{"id":"2560543271","title":"信达生物跌1.91% 股价跌破100港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2560543271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560543271?lang=zh_cn&edition=full","pubTime":"2025-08-19 10:01","pubTimestamp":1755568919,"startTime":"0","endTime":"0","summary":"2025年08月19日早盘10时01分，信达生物股票出现异动，股价急速跳水1.91%。截至发稿，该股报99.950港元/股，成交量300.607万股，换手率0.18%，振幅2.94%。资金方面，该股资金流入1.14671亿港元，流出1.54423亿港元。信达生物股票所在的药品行业中，整体涨幅为0.55%。其相关个股中，翰森制药、雅各臣科研制药、联邦制药涨幅较大，振幅较大的相关个股有联邦制药、九源基因、顺腾国际控股，振幅分别为18.20%、10.17%、10.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819100159a490b1fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819100159a490b1fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4231","BK4139","ADC","BK4080","CVM"],"gpt_icon":0},{"id":"2558672786","title":"Cel-Sci Corporation盘中异动 临近收盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558672786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558672786?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:34","pubTimestamp":1754940863,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时34分，Cel-Sci Corporation股票出现波动，股价急速下跌5.21%。截至发稿，该股报7.05美元/股，成交量16.6931万股，换手率3.25%，振幅10.05%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6199.61%、651.88%、561.25%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081203342394dd417e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081203342394dd417e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2557595809","title":"Cel-Sci Corporation盘中异动 急速下挫5.96%报8.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557595809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557595809?lang=zh_cn&edition=full","pubTime":"2025-08-08 02:54","pubTimestamp":1754592882,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日02时54分，Cel-Sci Corporation股票出现异动，股价快速下挫5.96%。截至发稿，该股报8.60美元/股，成交量15.4745万股，换手率3.01%，振幅7.99%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1852.78%、220.37%、109.86%，振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为105.51%、82.50%、59.72%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808025442a47b8607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808025442a47b8607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2557970433","title":"Cel-Sci Corporation盘中异动 早盘大幅跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557970433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557970433?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:01","pubTimestamp":1754402483,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日22时01分，Cel-Sci Corporation股票出现异动，股价大幅下跌5.84%。截至发稿，该股报8.71美元/股，成交量4.36万股，换手率0.85%，振幅8.43%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为2.99%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Bioxcel Therapeutics, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为135.21%、122.66%、95.92%，振幅较大的相关个股有Shattuck Labs, Inc.、Bioxcel Therapeutics, Inc.、Calidi Biotherapeutics, Inc.，振幅分别为27.17%、26.77%、20.02%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080522012397357506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080522012397357506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139","STTK"],"gpt_icon":0},{"id":"2556238292","title":"Cel-Sci Corporation盘中异动 早盘急速拉升5.71%报9.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556238292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556238292?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:33","pubTimestamp":1754314409,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时33分，Cel-Sci Corporation股票出现波动，股价快速拉升5.71%。截至发稿，该股报9.99美元/股，成交量3.7841万股，换手率0.74%，振幅4.25%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Soligenix, Inc.涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2368.11%、847.17%、398.30%，振幅较大的相关个股有Psyence Biomedical Ltd.、Soligenix, Inc.、凯信远达，振幅分别为29.45%、20.98%、15.35%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421332994cee813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421332994cee813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2555398008","title":"Cel-Sci Corporation盘中异动 急速上涨6.29%报9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555398008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555398008?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:45","pubTimestamp":1753969549,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时45分，Cel-Sci Corporation股票出现异动，股价快速拉升6.29%。截至发稿，该股报9.12美元/股，成交量8.3479万股，换手率1.63%，振幅3.81%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为2.39%。其相关个股中，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为3788.91%、3001.59%、2142.36%，振幅较大的相关个股有Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为42.41%、37.60%、33.00%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731214550a46db9e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731214550a46db9e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2555528670","title":"Cel-Sci Corporation盘中异动 早盘股价大跌5.92%报8.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555528670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555528670?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:40","pubTimestamp":1753796418,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时40分，Cel-Sci Corporation股票出现波动，股价快速下挫5.92%。截至发稿，该股报8.10美元/股，成交量12.2712万股，换手率2.39%，振幅7.90%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Scinai Immunotherapeutics Ltd、Calidi Biotherapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为3058.39%、1256.92%、335.10%，振幅较大的相关个股有Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为43.41%、29.04%、26.88%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921401897258937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921401897258937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2554975772","title":"Cel-Sci Corporation盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554975772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554975772?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:31","pubTimestamp":1753709486,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时31分，Cel-Sci Corporation股票出现异动，股价急速上涨5.05%。截至发稿，该股报8.61美元/股，成交量6.001万股，换手率1.17%，振幅4.59%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为221.80%、80.88%、80.33%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lexaria Bioscience Corp.，振幅分别为35.83%、23.86%、10.21%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213126a6c61540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213126a6c61540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2553479985","title":"基金2季报收官，公募对AI和创新药的“偏爱”，藏都不藏了","url":"https://stock-news.laohu8.com/highlight/detail?id=2553479985","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553479985?lang=zh_cn&edition=full","pubTime":"2025-07-21 18:08","pubTimestamp":1753092480,"startTime":"0","endTime":"0","summary":"来源：华尔街见闻抄底AI和创新药2025年公募基金2季报，日前全部发布完毕。在这个转折的季节，公募基金对A股的偏好和增减仓，态度十分明显。根据WIND对截至7月21日下午4点的发布统计，公募基金年中的十大重仓股中，AI概念股大获追捧。此外，创新药企业也迎来了不少基金经理的“追捧”。尤其值得一提的是，主动公募基金对中际旭创、新易盛的持股总市值，在2季度增长了百亿元以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721193108a4596751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721193108a4596751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03750","06936","00981","01530","02899","00300","01801","BK4139","ZIJMF","600760","688981","ZIJMY","600519","601899","BK4017","01810","CVM","09988"],"gpt_icon":0},{"id":"2552480707","title":"Cel-Sci Corporation盘中异动 早盘股价大涨5.97%报4.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552480707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552480707?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:33","pubTimestamp":1752762820,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时33分，Cel-Sci Corporation股票出现波动，股价急速上涨5.97%。截至发稿，该股报4.08美元/股，成交量12.5995万股，换手率2.45%，振幅5.84%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃，换手率分别为857.24%、362.95%、187.85%，振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为148.12%、81.11%、61.18%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722334097a9e472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722334097a9e472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2551256311","title":"Cel-Sci Corporation盘中异动 早盘快速下挫6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551256311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551256311?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:30","pubTimestamp":1752672608,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时30分，Cel-Sci Corporation股票出现波动，股价快速跳水6.52%。截至发稿，该股报3.30美元/股，成交量4.0872万股，换手率0.80%，振幅0.00%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Windtree Therapeutics, Inc.、Abivax、Calidi Biotherapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1384.30%、875.91%、360.44%，振幅较大的相关个股有Kala Bio, Inc.、Nanoviricides, Inc.、Kairos Pharma, Ltd.，振幅分别为8.22%、3.08%、2.14%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213008a44ede37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213008a44ede37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2550252776","title":"Cel-Sci Corporation盘中异动 早盘大幅拉升8.57%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550252776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550252776?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154293,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Cel-Sci Corporation股票出现波动，股价急速上涨8.57%。截至发稿，该股报3.04美元/股，成交量5.157万股，换手率1.00%，振幅2.14%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Cognition Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Neonc Technologies Holdings, Inc.涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为194.53%、116.01%、59.08%，振幅较大的相关个股有Nurix Therapeutics, Inc.、Cognition Therapeutics, Inc.、Nextcure, Inc.，振幅分别为13.74%、13.34%、11.47%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213133a6a1c116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213133a6a1c116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVM","BK4139","CGTX"],"gpt_icon":0},{"id":"2550753521","title":"Cel-Sci Corporation盘中异动 大幅上涨5.84%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550753521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550753521?lang=zh_cn&edition=full","pubTime":"2025-07-09 00:18","pubTimestamp":1751991498,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日00时18分，Cel-Sci Corporation股票出现波动，股价快速上涨5.84%。截至发稿，该股报2.42美元/股，成交量2.5732万股，换手率0.50%，振幅3.49%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，Prokidney Corp.、Zyversa Therapeutics, Inc.、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为3196.62%、587.96%、333.09%，振幅较大的相关个股有Prokidney Corp.、Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为402.29%、146.75%、73.81%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709001819a43e6e4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709001819a43e6e4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2549553166","title":"Cel-Sci Corporation盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549553166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549553166?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:25","pubTimestamp":1751898332,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时25分，Cel-Sci Corporation股票出现异动，股价大幅跳水5.22%。截至发稿，该股报2.36美元/股，成交量3.0758万股，换手率0.60%，振幅4.42%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为3696.97%、1068.54%、805.78%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为244.54%、93.67%、84.08%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707222533979d2360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707222533979d2360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2548308819","title":"Cel-Sci Corporation盘中异动 早盘大幅上涨5.06%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548308819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548308819?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:24","pubTimestamp":1751469883,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时24分，Cel-Sci Corporation股票出现波动，股价急速拉升5.06%。截至发稿，该股报2.49美元/股，成交量5.7643万股，换手率1.12%，振幅4.22%。Cel-Sci Corporation股票所在的生物技术行业中，整体涨幅为0.98%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702232443a4cb7cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702232443a4cb7cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cel-sci.com","stockEarnings":[{"period":"1week","weight":-0.1591},{"period":"1month","weight":-0.1213},{"period":"3month","weight":-0.3851},{"period":"6month","weight":1.7101},{"period":"1year","weight":-0.6163},{"period":"ytd","weight":-0.4624}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CEL-SCI Corporation于1983年3月22日成立注册于科罗拉多州，主要致力于现代营销学，生物科学的发展并最终致力于产品的销售。该公司旨在利用免疫系统和身体的自然抵抗系统来研究和提高癌症和其它疾病的治疗。它主导的调查型治疗方法就是Multikine，目前正处于关键的第三临床研究阶段。CEL-SCI也在试验一项免疫疗法，看其对于感染HINI的患者有无治愈的可能，它还利用其先进的技术平台测试该疗法能否治愈风湿性关节炎。该调查性免疫疗法——LEAPS-H1N1-DC，包含了HINI流感、禽流感和西班牙流感的不变性，科学家们担心新的更致病性的病毒会因为这几种流感的结合而出现。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.169703},{"month":2,"riseRate":0.309524,"avgChangeRate":0.01534},{"month":3,"riseRate":0.357143,"avgChangeRate":-0.03149},{"month":4,"riseRate":0.571429,"avgChangeRate":0.124059},{"month":5,"riseRate":0.261905,"avgChangeRate":-0.022981},{"month":6,"riseRate":0.404762,"avgChangeRate":0.006132},{"month":7,"riseRate":0.190476,"avgChangeRate":-0.002919},{"month":8,"riseRate":0.357143,"avgChangeRate":0.039997},{"month":9,"riseRate":0.357143,"avgChangeRate":0.046322},{"month":10,"riseRate":0.309524,"avgChangeRate":-0.077364},{"month":11,"riseRate":0.404762,"avgChangeRate":0.012679},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.009433}],"exchange":"AMEX","name":"CEL-SCI Corp","nameEN":"CEL-SCI Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CEL-SCI Corp(CVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CEL-SCI Corp(CVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CEL-SCI Corp,CVM,CEL-SCI Corp股票,CEL-SCI Corp股票老虎,CEL-SCI Corp股票老虎国际,CEL-SCI Corp行情,CEL-SCI Corp股票行情,CEL-SCI Corp股价,CEL-SCI Corp股市,CEL-SCI Corp股票价格,CEL-SCI Corp股票交易,CEL-SCI Corp股票购买,CEL-SCI Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CEL-SCI Corp(CVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CEL-SCI Corp(CVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}